Latest Updates & News
Breaking the Pain Cycle: Understanding Increased Sensitivity to Pain in Opioid Use Disorder
What Did the Research Discover? This study looked at whether people with a history of opioid use disorder (OUD) experience increased pain sensitivity and if this is linked to opioid use. Researchers analyzed 39 studies involving over 1,300 people with OUD and 700 people without OUD. The main focus was on how patients responded to cold pain, measured using a cold...
New Breakthrough in Aggressive Breast Cancer
https://youtu.be/sJVq4j4XEfc
Affordable Relief for Rheumatoid Arthritis: Biosimilars Prove Just as Effective as Original Drugs
What did the research discover? Researchers examined biosimilar drugs as a cost-effective alternative to biologic disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Biosimilars of adalimumab, etanercept, infliximab, and rituximab have been approved in the U.S. and Europe, offering comparable safety and effectiveness to their reference...
Brixadi Approved for Treatment of Opioid Use Disorder on May 05, 2023
What is Brixadi prescribed for? Brixadi is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. What is the name of the drug and what does it do? Brixadi, pronounced brix-a-dee, (generic name:...
Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis
What is Zilbrysq prescribed for? Zilbrysq is prescribed to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive. What is the name of the drug and what does it do? Zilbrysq, pronounced ZIL-brisk, (generic name: zilucoplan) is for generalized myasthenia gravis (MG) treatment in adults. ...
Progress with Artificial Retina Implants in Patients with Macular Degeneration
What Did the Research Discover? Researchers studied how vision works and what happens when certain parts of the eye stop functioning properly. They focused on the retina, the thin layer of tissue at the back of the eye that helps us see by turning light into signals sent to the brain. The study explained how the retina has two types of photoreceptors: cones, which...